Efficacy and Safety of Rituximab in Hepatitis-B Virus-Associated PLA2R-positive Membranous Nephropathy

Kidney International Reports - United States
doi 10.1016/j.ekir.2017.09.009
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

Rituximab-Induced Depletion of Anti-Pla2r Autoantibodies Predicts Response in Membranous Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2011English

Response to Immunosuppressive Therapy in PLA2R- Associated and Non-Pla2r- Associated Idiopathic Membranous Nephropathy: A Retrospective, Multicenter Cohort Study

BMC Nephrology
Nephrology
2017English

PLA2R Antibodies and PLA2R Glomerular Deposits in Psoriasis Patients With Membranous Nephropathy

BMC Nephrology
Nephrology
2016English

Anti-Phospholipase A2 Receptor Antibody Positive Hepatitis B Virus-Associated Membranous Nephropathy Remitted With Entecavir After Relapse With Lamivudine

Journal of Nephropathology
Nephrology
2017English

Circulating Anti-Pla2r Autoantibodies to Monitor Immunological Activity in Membranous Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2011English

Non-Ischemic Cardiomyopathy After Rituximab Treatment for Membranous Nephropathy

Journal of Renal Injury Prevention
UrologyNephrology
2016English

Estimating Urinary Losses of Rituximab in Membranous Nephropathy With Nephrotic Range Proteinuria

Pathology
Forensic MedicinePathology
2020English

The Efficacy and Safety of Tenofovir in the Prevention of Hepatitis B Virus Recurrence Following Liver Transplantation

Turkish Journal of Gastroenterology
Gastroenterology
2015English

Membranous Nephropathy

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy